- Net sales were
$168 million , a 6% increase compared to the prior year, with a 3% increase in organic sales1. - IT&S Product sales increased 5% organically year over year.
- Net earnings were
$29.8 million , or$0.58 per diluted share. Adjusted net earnings were$31.0 million , or$0.60 per diluted share. Reported and adjusted EPS include a$0.08 benefit related to the expected refund of tariffs imposed under the International Emergency Economic Powers Act (IEEPA). - Year-to-date operating cash flow was
$69 million , up from$56 million in the prior year. - Returned approximately
$15 million in the quarter to shareholders through share repurchases. - The company has updated its Fiscal 2026 guidance to reflect current conditions.
- For more details on the acquisition, refer to ir.enerpactoolgroup.com/news.
*This press release contains financial measures in accordance with
1Organic sales represent net sales excluding the impact of foreign exchange rates, acquisitions, and divestitures. A reconciliation of organic sales to comparable net sales is presented in the tables accompanying this release.
“We were pleased with the performance of our business and the solid growth we delivered in the third quarter of fiscal 2026,” said
As announced in a press release issued earlier today, Enerpac signed a definitive agreement to acquire
| Consolidated Results | |||||||
| (US$ in millions, except per share) | |||||||
| Three Months Ended | Nine Months Ended | ||||||
2026 | 2025 | 2026 | 2025 | ||||
| Net Earnings | 29.8 | 22.0 | 65.2 | 64.7 | |||
| Diluted EPS | 0.58 | 0.41 | 1.24 | 1.18 | |||
| Adjusted Diluted EPS | 0.60 | 0.51 | 1.35 | 1.29 | |||
| Adjusted EBITDA | 46.9 | 41.0 | 112.2 | 109.1 | |||
Third Quarter Fiscal 2026 Consolidated Results Comparisons
Consolidated net sales for the third quarter of fiscal 2026 were
Within IT&S, product sales increased 5% organically while service revenue declined 8% organically year over year. Service revenue improved 17% sequentially, demonstrating progress toward the Company’s profitable growth objectives.
Gross profit margin increased 260 basis points year over year to 53.0%, including the benefit from the expected refund of IEEPA tariffs.
Selling, general and administrative expenses (SG&A) of
Third quarter fiscal 2026 net earnings and diluted EPS were
Third quarter adjusted EBITDA was
Through the first nine months of fiscal 2026, the Company generated
| Balance Sheet and Leverage | ||||
| (US$ in millions) | ||||
| Cash Balance | ||||
| Debt Balance | ||||
| Net Debt to Adjusted EBITDA2 | 0.5x | 0.6x | 0.4x | |
Net debt on
Outlook
“We were pleased with the solid organic growth in our product business as well as the sequential improvement in Service,” said
The Company has narrowed and updated its fiscal 2026 guidance:
| Metric | Previous Full-Year Guidance | Revised Full-Year Guidance |
| Organic Growth | 1% to 3% | 1% to 2% |
| Adjusted EBITDA | ||
| Adjusted Diluted EPS | ||
| Free Cash Flow | No Change | |
Conference Call Information
An investor conference call is scheduled for
1Organic sales represent net sales excluding the impact of foreign exchange rates, acquisitions, and divestitures. A reconciliation of organic sales to comparable net sales is presented in the tables accompanying this release.
2Calculated in accordance with the terms of the Company’s
Safe Harbor Statement
Certain of the above comments represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. In addition to statements with respect to guidance, the terms “outlook,” “may,” “should,” “could,” “anticipate,” “believe,” “estimate,” “expect,” “objective,” “plan,” “project” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to inherent risks and uncertainties that may cause actual results or events to differ materially from those contemplated by such forward-looking statements. The following is a list of factors, among others, that could cause actual results to differ materially from the forward-looking statements, general economic uncertainty; the impact of geopolitical activity, including the armed conflicts in the
Non-GAAP Financial Information
This press release contains financial measures that are not measures presented in conformity with GAAP. These non-GAAP measures include organic sales, EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net earnings, adjusted diluted earnings per share, adjusted operating profit, segment adjusted operating profit and adjusted EBITDA, adjusted SG&A expense, free cash flow and net debt. This press release includes reconciliations of non-GAAP measures to the most comparable GAAP measure, included in the tables attached to this press release or in footnotes to the tables included in this press release. Management believes the non-GAAP measures presented in this press release are commonly used financial measures for investors to evaluate Enerpac Tool Group’s operating performance and financial position with respect to the periods presented and, when read in conjunction with the condensed consolidated financial statements, present a useful tool to evaluate ongoing operations and provide investors with metrics they can use to evaluate aspects of the Company’s performance from period to period. In addition, these are some of the financial metrics management uses in internal evaluations of the overall performance of the Company’s business. Management acknowledges that there are many items that impact a company’s reported results and the adjustments reflected in these non-GAAP measures are not intended to present all items that may have impacted these results. In addition, these non-GAAP measures are not necessarily comparable to similarly titled measures used by other companies. Adjusted diluted earnings per share anticipated for fiscal year 2026 is calculated in a manner consistent with the historical presentation of that measure in the accompanying tables. Because of the forward-looking nature of this estimate, it is impractical to present a quantitative reconciliation of this non-GAAP measure to the comparable GAAP measure, and accordingly no such GAAP measure for that period is being presented.
About
(tables follow)
| Condensed Consolidated Statements of Earnings | |||||||||||||||
| (In thousands, except per share amounts) | |||||||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net sales | $ | 167,553 | $ | 158,661 | $ | 466,568 | $ | 449,385 | |||||||
| Cost of products sold | 78,769 | 78,758 | 232,787 | 221,400 | |||||||||||
| Gross profit | 88,784 | 79,903 | 233,781 | 227,985 | |||||||||||
| Selling, general and administrative expenses | 45,819 | 41,125 | 130,958 | 124,865 | |||||||||||
| Amortization of intangible assets | 1,597 | 1,235 | 4,663 | 3,625 | |||||||||||
| Restructuring charges | - | 5,862 | 3,283 | 5,862 | |||||||||||
| Operating profit | 41,368 | 31,681 | 94,877 | 93,633 | |||||||||||
| Financing costs, net | 2,262 | 2,395 | 6,637 | 7,535 | |||||||||||
| Other expense, net | 413 | 947 | 1,875 | 2,184 | |||||||||||
| Earnings before income tax expense | 38,693 | 28,339 | 86,365 | 83,914 | |||||||||||
| Income tax expense | 8,895 | 6,295 | 21,127 | 19,246 | |||||||||||
| Net earnings | $ | 29,798 | $ | 22,044 | $ | 65,238 | $ | 64,668 | |||||||
| Earnings per share | |||||||||||||||
| Basic | $ | 0.58 | $ | 0.41 | $ | 1.25 | $ | 1.19 | |||||||
| Diluted | 0.58 | 0.41 | 1.24 | 1.18 | |||||||||||
| Weighted average common shares outstanding | |||||||||||||||
| Basic | 51,316 | 54,051 | 52,059 | 54,230 | |||||||||||
| Diluted | 51,568 | 54,417 | 52,405 | 54,679 | |||||||||||
| Condensed Consolidated Balance Sheets | |||||||
| (In thousands) | |||||||
| (Unaudited) | |||||||
| 2026 | 2025 | ||||||
| Assets | |||||||
| Current assets | |||||||
| Cash and cash equivalents | $ | 115,680 | $ | 151,558 | |||
| Accounts receivable, net | 105,866 | 106,085 | |||||
| Inventories, net | 84,995 | 78,774 | |||||
| Other current assets | 51,975 | 39,701 | |||||
| Total current assets | 358,516 | 376,118 | |||||
| Property, plant and equipment, net | 54,843 | 53,275 | |||||
| 289,516 | 289,787 | ||||||
| Other intangible assets, net | 44,412 | 46,942 | |||||
| Other long-term assets | 64,256 | 61,745 | |||||
| Total assets | $ | 811,543 | $ | 827,867 | |||
| Liabilities and Shareholders' Equity | |||||||
| Current liabilities | |||||||
| Current maturities of long-term debt | $ | 10,000 | $ | 7,500 | |||
| Trade accounts payable | 38,146 | 42,944 | |||||
| Accrued compensation and benefits | 25,001 | 28,108 | |||||
| Income taxes payable | 9,178 | 5,425 | |||||
| Other current liabilities | 51,945 | 53,125 | |||||
| Total current liabilities | 134,270 | 137,102 | |||||
| Long-term debt, net | 174,793 | 182,168 | |||||
| Deferred income taxes | 7,223 | 6,192 | |||||
| Pension and postretirement benefit liabilities | 6,349 | 7,147 | |||||
| Other long-term liabilities | 64,880 | 61,564 | |||||
| Total liabilities | 387,515 | 394,173 | |||||
| Shareholders' equity | |||||||
| Common stock | 10,226 | 10,589 | |||||
| Additional paid-in capital | 247,909 | 243,137 | |||||
| Retained earnings | 268,620 | 284,102 | |||||
| Accumulated other comprehensive loss | (102,727 | ) | (104,134 | ) | |||
| Stock held in trust | (4,860 | ) | (3,542 | ) | |||
| Deferred compensation liability | 4,860 | 3,542 | |||||
| Total shareholders' equity | 424,028 | 433,694 | |||||
| Total liabilities and shareholders' equity | $ | 811,543 | $ | 827,867 | |||
| Condensed Consolidated Statements of Cash Flows | |||||||
| (In thousands) | |||||||
| (Unaudited) | |||||||
| Nine Months Ended | |||||||
| 2026 | 2025 | ||||||
| Operating Activities | |||||||
| Cash provided by operating activities | $ | 69,263 | $ | 56,030 | |||
| Investing Activities | |||||||
| Capital expenditures | (9,241 | ) | (16,360 | ) | |||
| Cash paid for business acquisitions, net of cash acquired | - | (26,744 | ) | ||||
| Other | (2,007 | ) | - | ||||
| Cash used in investing activities | $ | (11,248 | ) | $ | (43,104 | ) | |
| Financing Activities | |||||||
| Principal repayments on term loan | (5,000 | ) | (3,750 | ) | |||
| Borrowings on revolving credit facility | 14,000 | 14,421 | |||||
| Principal repayments on revolving credit facility | (14,000 | ) | (14,421 | ) | |||
| Purchase of treasury shares | (81,134 | ) | (28,594 | ) | |||
| Stock options and taxes paid related to the net share settlement of equity awards | (4,570 | ) | (5,460 | ) | |||
| Payment of cash dividend | (2,119 | ) | (2,167 | ) | |||
| Other | (949 | ) | - | ||||
| Cash used in financing activities | $ | (93,772 | ) | $ | (39,971 | ) | |
| Effect of exchange rate changes on cash | (121 | ) | 457 | ||||
| Net decrease from cash and cash equivalents | $ | (35,878 | ) | $ | (26,588 | ) | |
| Cash and cash equivalents - beginning of period | 151,558 | 167,094 | |||||
| Cash and cash equivalents - end of period | $ | 115,680 | $ | 140,506 | |||
| Supplemental Unaudited Data | ||||||||||||||||||||||||||||||
| Reconciliation of GAAP Measures to Non-GAAP Measures | ||||||||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||
| Fiscal 2025 | Fiscal 2026 | |||||||||||||||||||||||||||||
| Q1 | Q2 | Q3 | Q4 | TOTAL | Q1 | Q2 | Q3 | Q4 | TOTAL | |||||||||||||||||||||
| $ | 140,134 | $ | 140,716 | $ | 153,374 | $ | 161,602 | $ | 595,825 | $ | 137,762 | $ | 148,685 | $ | 160,966 | $ | - | $ | 447,413 | |||||||||||
| Other | 5,062 | 4,812 | 5,287 | 5,913 | 21,074 | 6,446 | 6,122 | 6,587 | - | 19,155 | ||||||||||||||||||||
| $ | 145,196 | $ | 145,528 | $ | 158,661 | $ | 167,515 | $ | 616,899 | $ | 144,208 | $ | 154,807 | $ | 167,553 | $ | - | $ | 466,568 | |||||||||||
| % Net Sales Growth (Decline) Year over Year | ||||||||||||||||||||||||||||||
| 2 | % | 4 | % | 5 | % | 5 | % | 4 | % | -2 | % | 6 | % | 5 | % | - | 3 | % | ||||||||||||
| Other | 3 | % | 33 | % | 19 | % | 10 | % | 15 | % | 27 | % | 27 | % | 25 | % | - | 26 | % | |||||||||||
| 2 | % | 5 | % | 6 | % | 6 | % | 5 | % | -1 | % | 6 | % | 6 | % | - | 4 | % | ||||||||||||
| Adjusted Selling, general and administrative expenses | ||||||||||||||||||||||||||||||
| Selling, general and administrative expenses | $ | 42,318 | $ | 41,423 | $ | 41,125 | $ | 42,055 | $ | 166,920 | $ | 43,095 | $ | 42,042 | $ | 45,819 | $ | - | $ | 130,958 | ||||||||||
| M&A charges (1) | (152 | ) | (258 | ) | (714 | ) | (292 | ) | (1,415 | ) | (91 | ) | (1,118 | ) | (1,577 | ) | - | (2,786 | ) | |||||||||||
| Adjusted Selling, general and administrative expenses | $ | 42,166 | $ | 41,165 | $ | 40,411 | $ | 41,763 | $ | 165,505 | $ | 43,004 | $ | 40,924 | $ | 44,242 | $ | - | $ | 128,172 | ||||||||||
| Adjusted Selling, general and administrative expenses % | ||||||||||||||||||||||||||||||
| 29.0 | % | 28.3 | % | 25.5 | % | 24.9 | % | 26.8 | % | 29.8 | % | 26.4 | % | 26.4 | % | - | 27.5 | % | ||||||||||||
| Adjusted Operating profit | ||||||||||||||||||||||||||||||
| Operating profit | $ | 31,132 | $ | 30,820 | $ | 31,681 | $ | 39,837 | $ | 133,471 | $ | 28,490 | $ | 25,020 | $ | 41,368 | $ | - | $ | 94,877 | ||||||||||
| Restructuring charges | - | - | 5,862 | - | 5,862 | - | 3,283 | - | - | 3,283 | ||||||||||||||||||||
| M&A charges | 152 | 261 | 714 | 292 | 1,419 | 91 | 1,120 | 1,577 | - | 2,788 | ||||||||||||||||||||
| Adjusted Operating profit | $ | 31,284 | $ | 31,081 | $ | 38,257 | $ | 40,129 | $ | 140,752 | $ | 28,581 | $ | 29,423 | $ | 42,945 | $ | - | $ | 100,948 | ||||||||||
| Adjusted Operating profit by Segment | ||||||||||||||||||||||||||||||
| $ | 38,074 | $ | 38,748 | $ | 42,837 | $ | 47,092 | $ | 166,751 | $ | 35,740 | $ | 34,834 | $ | 48,739 | $ | - | $ | 119,312 | |||||||||||
| Other | 1,319 | 1,301 | 2,083 | 1,360 | 6,063 | 2,214 | 1,595 | 2,073 | - | 5,882 | ||||||||||||||||||||
| (8,109 | ) | (8,968 | ) | (6,663 | ) | (8,323 | ) | (32,062 | ) | (9,373 | ) | (7,006 | ) | (7,867 | ) | - | (24,246 | ) | ||||||||||||
| Adjusted operating profit | $ | 31,284 | $ | 31,081 | $ | 38,257 | $ | 40,129 | $ | 140,752 | $ | 28,581 | $ | 29,423 | $ | 42,945 | $ | - | $ | 100,948 | ||||||||||
| Adjusted Operating profit % | ||||||||||||||||||||||||||||||
| 27.2 | % | 27.5 | % | 27.9 | % | 29.1 | % | 28.0 | % | 25.9 | % | 23.4 | % | 30.3 | % | - | 26.7 | % | ||||||||||||
| Other | 26.1 | % | 27.0 | % | 39.4 | % | 23.0 | % | 28.8 | % | 34.3 | % | 26.1 | % | 31.5 | % | - | 30.7 | % | |||||||||||
| Adjusted Operating Profit % | 21.5 | % | 21.4 | % | 24.1 | % | 24.0 | % | 22.8 | % | 19.8 | % | 19.0 | % | 25.6 | % | - | 21.6 | % | |||||||||||
| EBITDA (2) | ||||||||||||||||||||||||||||||
| Net earnings | $ | 21,723 | $ | 20,901 | $ | 22,044 | $ | 28,080 | $ | 92,749 | $ | 19,131 | $ | 16,308 | $ | 29,798 | $ | - | $ | 65,238 | ||||||||||
| Financing costs, net | 2,770 | 2,371 | 2,395 | 2,376 | 9,911 | 2,265 | 2,111 | 2,262 | - | 6,637 | ||||||||||||||||||||
| Income tax expense | 6,152 | 6,798 | 6,295 | 8,734 | 27,980 | 6,426 | 5,807 | 8,895 | - | 21,127 | ||||||||||||||||||||
| Depreciation & amortization | 3,514 | 3,471 | 3,721 | 4,968 | 15,674 | 4,448 | 4,336 | 4,349 | - | 13,133 | ||||||||||||||||||||
| EBITDA | $ | 34,159 | $ | 33,541 | $ | 34,455 | $ | 44,158 | $ | 146,314 | $ | 32,270 | $ | 28,562 | $ | 45,304 | $ | - | $ | 106,135 | ||||||||||
| Adjusted EBITDA (2) | ||||||||||||||||||||||||||||||
| EBITDA | $ | 34,159 | $ | 33,541 | $ | 34,455 | $ | 44,158 | $ | 146,314 | $ | 32,270 | $ | 28,562 | $ | 45,304 | $ | - | $ | 106,135 | ||||||||||
| Restructuring charges | - | - | 5,862 | - | 5,862 | - | 3,283 | - | - | 3,283 | ||||||||||||||||||||
| M&A charges | 152 | 261 | 714 | 292 | 1,419 | 91 | 1,120 | 1,577 | - | 2,788 | ||||||||||||||||||||
| Adjusted EBITDA (2) | $ | 34,311 | $ | 33,802 | $ | 41,031 | $ | 44,450 | $ | 153,595 | $ | 32,361 | $ | 32,965 | $ | 46,881 | $ | - | $ | 112,206 | ||||||||||
| Adjusted EBITDA (2) by Segment | ||||||||||||||||||||||||||||||
| $ | 40,807 | $ | 41,313 | $ | 45,317 | $ | 50,726 | $ | 178,163 | $ | 38,903 | $ | 37,916 | $ | 51,901 | $ | - | $ | 128,719 | |||||||||||
| Other | 1,546 | 1,525 | 2,309 | 1,579 | 6,959 | 2,462 | 1,808 | 2,266 | - | 6,536 | ||||||||||||||||||||
| (8,042 | ) | (9,036 | ) | (6,595 | ) | (7,855 | ) | (31,527 | ) | (9,004 | ) | (6,759 | ) | (7,286 | ) | - | (23,049 | ) | ||||||||||||
| Adjusted EBITDA (2) | $ | 34,311 | $ | 33,802 | $ | 41,031 | $ | 44,450 | $ | 153,595 | $ | 32,361 | $ | 32,965 | $ | 46,881 | $ | - | $ | 112,206 | ||||||||||
| Adjusted EBITDA % (2) | ||||||||||||||||||||||||||||||
| 29.1 | % | 29.4 | % | 29.5 | % | 31.4 | % | 29.9 | % | 28.2 | % | 25.5 | % | 32.2 | % | - | 28.8 | % | ||||||||||||
| Other | 30.5 | % | 31.7 | % | 43.7 | % | 26.7 | % | 33.0 | % | 38.2 | % | 29.5 | % | 34.4 | % | - | 34.1 | % | |||||||||||
| Adjusted EBITDA % (2) | 23.6 | % | 23.2 | % | 25.9 | % | 26.5 | % | 24.9 | % | 22.4 | % | 21.3 | % | 28.0 | % | - | 24.0 | % | |||||||||||
| Notes: | ||||||||||||||||||||||||||||||
| (1) Minimal amounts of M&A Charges were recorded in cost of products sold in Q2 Fiscal 2026 and 2025 | ||||||||||||||||||||||||||||||
| (2) EBITDA represents net earnings before financing costs, net, income tax expense, and depreciation & amortization. Neither EBITDA nor adjusted EBITDA are calculated based upon generally accepted accounting principles ("GAAP"). The amounts included in the EBITDA and adjusted EBITDA calculation, however, are derived from amounts included in the Condensed Consolidated Statements of Earnings. EBITDA and adjusted EBITDA should not be considered as alternatives to net earnings, operating profit or operating cash flows. The Company has presented EBITDA and adjusted EBITDA because it regularly reviews these performance measures. In addition, EBITDA and adjusted EBITDA are used by many of our investors and lenders, and are presented as a convenience to them. The EBITDA and adjusted EBITDA measures presented may not always be comparable to similarly titled measures reported by other companies due to differences in the components of the calculation. | ||||||||||||||||||||||||||||||
| Supplemental Unaudited Data | |||||||||||||||||||||
| Reconciliation of GAAP Measures to Non-GAAP Measures (Continued) | |||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||
| Fiscal 2025 | Fiscal 2026 | ||||||||||||||||||||
| Q1 | Q2 | Q3 | YTD | Q1 | Q2 | Q3 | YTD | ||||||||||||||
| $ | 140,134 | $ | 140,716 | $ | 153,374 | $ | 434,224 | $ | 137,762 | $ | 148,685 | $ | 160,966 | $ | 447,413 | ||||||
| Other | 5,062 | 4,812 | 5,287 | 15,161 | 6,446 | 6,122 | 6,587 | 19,155 | |||||||||||||
| $ | 145,196 | $ | 145,528 | $ | 158,661 | $ | 449,385 | $ | 144,208 | $ | 154,807 | $ | 167,553 | $ | 466,568 | ||||||
| Adjustment: Fx Impact on | |||||||||||||||||||||
| $ | 2,532 | $ | 6,057 | $ | 3,746 | $ | 12,336 | $ | - | $ | - | $ | - | $ | - | ||||||
| Other | - | - | - | - | - | - | - | - | |||||||||||||
| $ | 2,532 | $ | 6,057 | $ | 3,746 | $ | 12,336 | $ | - | $ | - | $ | - | $ | - | ||||||
| Adjustment: Impact from Divestitures or Acquisitions on | |||||||||||||||||||||
| - | - | - | - | - | - | - | - | ||||||||||||||
| Other | - | - | - | - | - | - | - | - | |||||||||||||
| $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||||||
| Organic Sales by Segment (3) | |||||||||||||||||||||
| $ | 142,666 | $ | 146,773 | $ | 157,120 | $ | 446,560 | $ | 137,762 | $ | 148,685 | $ | 160,966 | $ | 447,413 | ||||||
| Other | 5,062 | 4,812 | 5,287 | 15,161 | 6,446 | 6,122 | 6,587 | 19,155 | |||||||||||||
| $ | 147,728 | $ | 151,585 | $ | 162,407 | $ | 461,721 | $ | 144,208 | $ | 154,807 | $ | 167,553 | $ | 466,568 | ||||||
| Organic Sales Growth (Decline) % (3) | |||||||||||||||||||||
| (3 | %) | 1 | % | 2 | % | 0 | % | ||||||||||||||
| Other | 27 | % | 27 | % | 25 | % | 26 | % | |||||||||||||
| (2 | %) | 2 | % | 3 | % | 1 | % | ||||||||||||||
| $ | 106,087 | $ | 113,880 | $ | 124,308 | $ | 344,274 | $ | 112,111 | $ | 125,313 | $ | 133,531 | $ | 370,956 | ||||||
| 34,047 | 26,836 | 29,066 | 89,950 | 25,651 | 23,372 | 27,435 | 76,457 | ||||||||||||||
| $ | 140,134 | $ | 140,716 | $ | 153,374 | $ | 434,224 | $ | 137,762 | $ | 148,685 | $ | 160,966 | $ | 447,413 | ||||||
| Adjustment: Fx Impact on | |||||||||||||||||||||
| $ | 1,760 | $ | 4,788 | $ | 2,878 | $ | 9,427 | $ | - | $ | - | $ | - | $ | - | ||||||
| 772 | 1,269 | 868 | 2,909 | - | - | - | - | ||||||||||||||
| $ | 2,532 | $ | 6,057 | $ | 3,746 | $ | 12,336 | $ | - | $ | - | $ | - | $ | - | ||||||
| Adjustment: Impact from Divestitures or Acquisitions on | |||||||||||||||||||||
| - | - | - | - | - | - | - | - | ||||||||||||||
| - | - | - | - | - | - | - | - | ||||||||||||||
| $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||||||
| $ | 107,847 | $ | 118,668 | $ | 127,186 | $ | 353,701 | $ | 112,111 | $ | 125,313 | $ | 133,531 | $ | 370,956 | ||||||
| 34,819 | 28,105 | 29,934 | 92,859 | 25,651 | 23,372 | 27,435 | 76,457 | ||||||||||||||
| $ | 142,666 | $ | 146,773 | $ | 157,120 | $ | 446,560 | $ | 137,762 | $ | 148,685 | $ | 160,966 | $ | 447,413 | ||||||
| Organic Sales Growth (Decline) % (3) | |||||||||||||||||||||
| 4 | % | 6 | % | 5 | % | 5 | % | ||||||||||||||
| (26 | %) | (17 | %) | (8 | %) | (18 | %) | ||||||||||||||
| (3 | %) | 1 | % | 2 | % | 0 | % | ||||||||||||||
| Notes continued: | |||||||||||||||||||||
| (3) Organic Sales is defined as sales excluding the impact to foreign currency changes and the impact from recent acquisitions and divestitures to net sales. | |||||||||||||||||||||
| Supplemental Unaudited Data | |||||||||||||||||||||||||||||
| Reconciliation of GAAP Measures to Non-GAAP Measures (Continued) | |||||||||||||||||||||||||||||
| (In thousands, except per share amounts) | |||||||||||||||||||||||||||||
| Fiscal 2025 | Fiscal 2026 | ||||||||||||||||||||||||||||
| Q1 | Q2 | Q3 | Q4 | TOTAL | Q1 | Q2 | Q3 | Q4 | TOTAL | ||||||||||||||||||||
| Adjusted Earnings (4) | |||||||||||||||||||||||||||||
| Net Earnings | $ | 21,723 | $ | 20,901 | $ | 22,044 | $ | 28,080 | $ | 92,749 | $ | 19,131 | $ | 16,308 | $ | 29,798 | $ | - | $ | 65,238 | |||||||||
| Restructuring charges | - | - | 5,862 | - | 5,862 | - | 3,283 | - | - | 3,283 | |||||||||||||||||||
| M&A charges | 152 | 261 | 714 | 292 | 1,419 | 91 | 1,120 | 1,577 | - | 2,788 | |||||||||||||||||||
| Net tax effect of reconciling items above | (4 | ) | 1 | (910 | ) | (492 | ) | (1,406 | ) | (20 | ) | (365 | ) | (373 | ) | - | (759 | ) | |||||||||||
| Adjusted Net Earnings | $ | 21,871 | $ | 21,163 | $ | 27,710 | $ | 27,880 | $ | 98,624 | $ | 19,202 | $ | 20,346 | $ | 31,002 | $ | - | $ | 70,550 | |||||||||
| Adjusted Diluted Earnings per share (4) | |||||||||||||||||||||||||||||
| Diluted Earnings per share | $ | 0.40 | $ | 0.38 | $ | 0.41 | $ | 0.52 | $ | 1.70 | $ | 0.36 | $ | 0.31 | $ | 0.58 | $ | - | $ | 1.24 | |||||||||
| Restructuring charges, net of tax effect | - | - | 0.09 | (0.01 | ) | 0.09 | - | 0.06 | 0.00 | - | 0.05 | ||||||||||||||||||
| M&A charges, net of tax effect | 0.00 | 0.00 | 0.01 | 0.00 | 0.02 | 0.00 | 0.02 | 0.03 | - | 0.05 | |||||||||||||||||||
| Adjusted Diluted Earnings per share | $ | 0.40 | $ | 0.39 | $ | 0.51 | $ | 0.52 | $ | 1.81 | $ | 0.36 | $ | 0.39 | $ | 0.60 | $ | - | $ | 1.35 | |||||||||
| Notes continued: | |||||||||||||||||||||||||||||
| (4) Adjusted earnings and adjusted diluted earnings per share represent net earnings and diluted earnings per share per the Condensed Consolidated Statements of Earnings net of charges or credits for items to be highlighted for comparability purposes. These measures are not calculated based upon GAAP and should not be considered as an alternative to net earnings or diluted earnings per share or as an indicator of the Company's operating performance. However, this presentation is important to investors for understanding the operating results of | |||||||||||||||||||||||||||||
| For all reconciliations of GAAP measures to Non-GAAP measures, the summation of the individual components may not equal the total due to rounding. | |||||||||||||||||||||||||||||
| Supplemental Unaudited Data | ||||||
| Reconciliation of GAAP To Non-GAAP Guidance | ||||||
| (In millions) | ||||||
| Fiscal 2026 | ||||||
| Low | High | |||||
| Reconciliation of GAAP Operating Profit | ||||||
| To Adjusted EBITDA (5) | ||||||
| GAAP Operating profit | $ | 132 | $ | 139 | ||
| Restructuring charges | 3 | 3 | ||||
| Other expense, net | (2 | ) | (2 | ) | ||
| Depreciation & amortization | 18 | 16 | ||||
| Adjusted EBITDA | $ | 151 | $ | 156 | ||
| Reconciliation of GAAP Cash Flow From Operations to Free Cash Flow | ||||||
| Cash provided by operating activities | $ | 115 | $ | 120 | ||
| Capital expenditures | (15 | ) | (10 | ) | ||
| Free Cash Flow | $ | 100 | $ | 110 | ||
| Notes continued: | ||||||
| (5) Management does not provide guidance on certain GAAP financial measures as we are unable to predict and estimate with certainty items such as potential impairments, refinancing costs, business divestiture gains/losses, discrete tax adjustments, or other items impacting GAAP financial metrics. As a result, we have included only those items about which we are aware and are reasonably likely to occur during the guidance period covered. | ||||||
Contact:
Sr. Director, Investor Relations
+1 914 771 1770
Source: